C12N2770/36011 - CPC Classification

ssRNA viruses positive-sense; Details Togaviridae

• C12N2770/36021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 2
• C12N2770/36022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 0
• C12N2770/36023 » Virus like particles [VLP] 0
• C12N2770/36031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
• C12N2770/36032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 1
• C12N2770/36033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
• C12N2770/36034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 12
• C12N2770/36041 » Use of virus, viral particle or viral elements as a vector 0
• C12N2770/36051 » Methods of production or purification of viral material 3
• C12N2770/36061 » Methods of inactivation or attenuation 5
• C12N2770/36071 » Demonstrated in vivo effect 1
• C12N2770/36088 » For redistribution 0
• C12N2770/36111 » Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki 21
• C12N2770/36211 » Rubivirus, e.g. rubella virus 1

Recent Application in this class: